(MENAFN- Saudi Press Agency) Riyadh, January 24, 2022, SPA -- The Ministry of Investment of Saudi Arabia (MISA) and British pharmaceutical company GlaxoSmithKline Consumer HealthCare (GSK) have announced that they have signed an agreement to support the development of the medical self-care sector in the Kingdom.
As part of the agreement, MISA and GSK have agreed to work together to localize manufacturing, transfer knowledge and technology, and establish the Kingdom as a hub for research in the medical self-care industry.
Supporting the development of the self-care sector is expected to reduce overall healthcare costs by enabling people to tend more effectively to minor ailments themselves.
--SPA
19:22 LOCAL TIME 16:22 GMT
0032
MENAFN25012022000078011016ID1103588664
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.